{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:57:45Z","timestamp":1760853465836,"version":"3.44.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.yexcr.2010.01.016","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T05:47:32Z","timestamp":1263880052000},"page":"1263-1270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Antibody-assisted enhancement of biological activities of CXCL14 in human monocytic leukemia-derived THP-1 cells and high fat diet-induced obese mice"],"prefix":"10.1016","volume":"316","author":[{"given":"Kosuke","family":"Tanegashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2010.01.016_bib1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1006\/bbrc.1999.0257","article-title":"Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells","volume":"255","author":"Hromas","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2010.01.016_bib2","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0002-9440(10)65067-5","article-title":"In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue","volume":"156","author":"Frederick","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2010.01.016_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/intimm\/12.5.677","article-title":"B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokine","volume":"12","author":"Sleeman","year":"2000","journal-title":"Int. Immunol."},{"key":"10.1016\/j.yexcr.2010.01.016_bib4","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1111\/j.1432-1033.2004.04347.x","article-title":"chemokines are expressed early in ontogeny and at nonimmune sites","volume":"271","author":"Huising","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.yexcr.2010.01.016_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0083-6729(08)00605-5","article-title":"CXCL14 and insulin action","volume":"80","author":"Hara","year":"2009","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.yexcr.2010.01.016_bib6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1084\/jem.194.6.855","article-title":"Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development","volume":"194","author":"Kurth","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2010.01.016_bib7","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1158\/0008-5472.CAN-04-2056","article-title":"BRAK\/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells","volume":"64","author":"Shellenberger","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2010.01.016_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2005.08.012","article-title":"Cutaneous CXCL14 targets blood precursors to epidermal niches for langerhans cell differentiation","volume":"23","author":"Schaerli","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.yexcr.2010.01.016_bib9","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.174.9.5490","article-title":"Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo","volume":"174","author":"Shurin","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2010.01.016_bib10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.exphem.2006.05.015","article-title":"The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy","volume":"34","author":"Starnes","year":"2006","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.yexcr.2010.01.016_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","article-title":"Molecular characterization of the tumor microenvironment in breast cancer","volume":"6","author":"Allinen","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexcr.2010.01.016_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.canlet.2007.10.021","article-title":"CXCL14 expression and potential function in pancreatic cancer","volume":"259","author":"Wente","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2010.01.016_bib13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1128\/MCB.01648-06","article-title":"Murine CXCL14 is dispensable for dendritic cell function and localization within peripheral tissues","volume":"27","author":"Meuter","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2010.01.016_bib14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4049\/jimmunol.182.1.507","article-title":"Potent and broad-spectrum antimicrobial activity of CXCL14 suggests an immediate role in skin infections","volume":"182","author":"Maerki","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2010.01.016_bib15","doi-asserted-by":"crossref","first-page":"30794","DOI":"10.1074\/jbc.M700412200","article-title":"Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance","volume":"282","author":"Nara","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2010.01.016_bib16","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1158\/0008-5472.CAN-08-3359","article-title":"Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism","volume":"69","author":"Pelicano","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2010.01.016_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.2910260208","article-title":"Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)","volume":"26","author":"Tsuchiya","year":"1980","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2010.01.016_bib18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4049\/jimmunol.142.3.819","article-title":"A monoclonal antibody with IL-3-like activity blocks IL-3 binding and stimulates tyrosine phosphorylation","volume":"142","author":"Schreurs","year":"1989","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2010.01.016_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/pros.20215","article-title":"Modulation of CXCL14 (BRAK) expression in prostate cancer","volume":"64","author":"Schwarze","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.yexcr.2010.01.016_bib20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbrc.2006.07.070","article-title":"BRAK\/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells","volume":"348","author":"Ozawa","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2010.01.016_bib21","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1073\/pnas.0813144106","article-title":"CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth","volume":"106","author":"Augsten","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2010.01.016_bib22","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bbrc.2007.10.120","article-title":"CXCL14 enhances insulin-dependent glucose uptake in adipocytes and is related to high-fat diet-induced obesity","volume":"364","author":"Takahashi","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482710000273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482710000273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:07:47Z","timestamp":1757995667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482710000273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0014482710000273"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2010.01.016","relation":{},"ISSN":["0014-4827"],"issn-type":[{"type":"print","value":"0014-4827"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-assisted enhancement of biological activities of CXCL14 in human monocytic leukemia-derived THP-1 cells and high fat diet-induced obese mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2010.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}